Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
2021· article· en· New England Journal of Medicine· Medicine
aff
2,424
citations
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.
Direct labels are sparse and unvalidated. Missing labels are unknown.